Literature DB >> 22225629

Further evidence for a male-selective genetic association of synapse-associated protein 97 (SAP97) gene with schizophrenia.

Akihito Uezato1, Junko Kimura-Sato, Naoki Yamamoto, Yoshimi Iijima, Hiroshi Kunugi, Toru Nishikawa.   

Abstract

BACKGROUND: The synapse-associated protein 97 gene (SAP97) encodes a regulatory scaffold protein for the localization of L-alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA), kainate and N-methyl-D-aspartate (NMDA) type glutamate receptors. We have recently demonstrated nominally significant associations between SAP97 gene and schizophrenia among Japanese males. The present study aimed to replicate these findings using an independent and larger sample.
METHODS: We investigated seven SAP97 single nucleotide polymorphisms (SNPs) that displayed a significant association with schizophrenia in our preceding study in an independent Japanese population consisting of a total of 393 unrelated patients with schizophrenia (232 males and 161 females) and 393 unrelated control subjects (211 males and 182 females).
RESULTS: The SNP rs9843659 showed a significant genotypic association with male patients in a recessive model (p = 0.037). The analysis of the combined data from the current and prior studies also demonstrated a significant association of this SNP (p = 0.0039). The meta-analysis for the allele frequency covering the two studies yielded an odds ratio of 1.38.
CONCLUSIONS: The present study replicated the previously reported male-selective genetic association between the SAP97 polymorphism and schizophrenia. These findings further support the possible involvement of the SAP97 gene variation in the susceptibility to schizophrenia in males and in the genetic basis for sex differences in the disorder.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22225629      PMCID: PMC3275478          DOI: 10.1186/1744-9081-8-2

Source DB:  PubMed          Journal:  Behav Brain Funct        ISSN: 1744-9081            Impact factor:   3.759


  30 in total

1.  Haplotype transmission analysis provides evidence of association for DISC1 to schizophrenia and suggests sex-dependent effects.

Authors:  William Hennah; Teppo Varilo; Marjo Kestilä; Tiina Paunio; Ritva Arajärvi; Jari Haukka; Alex Parker; Rory Martin; Steve Levitzky; Timo Partonen; Joanne Meyer; Jouko Lönnqvist; Leena Peltonen; Jesper Ekelund
Journal:  Hum Mol Genet       Date:  2003-10-07       Impact factor: 6.150

2.  Quaternary structure, protein dynamics, and synaptic function of SAP97 controlled by L27 domain interactions.

Authors:  Terunaga Nakagawa; Kensuke Futai; Hilal A Lashuel; Irene Lo; Kenichi Okamoto; Thomas Walz; Yasunori Hayashi; Morgan Sheng
Journal:  Neuron       Date:  2004-10-28       Impact factor: 17.173

3.  Ketamine--its pharmacology and therapeutic uses.

Authors:  P F White; W L Way; A J Trevor
Journal:  Anesthesiology       Date:  1982-02       Impact factor: 7.892

4.  Cellular mechanisms for dopamine D4 receptor-induced homeostatic regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors.

Authors:  Eunice Y Yuen; Zhen Yan
Journal:  J Biol Chem       Date:  2011-05-27       Impact factor: 5.157

5.  Selective reduction of a PDZ protein, SAP-97, in the prefrontal cortex of patients with chronic schizophrenia.

Authors:  Kazuhiko Toyooka; Shuji Iritani; Takao Makifuchi; Osamu Shirakawa; Noboru Kitamura; Kiyoshi Maeda; Ryosuke Nakamura; Kazuhiro Niizato; Masahiko Watanabe; Akiyoshi Kakita; Hitoshi Takahashi; Toshiyuki Someya; Hiroyuki Nawa
Journal:  J Neurochem       Date:  2002-11       Impact factor: 5.372

Review 6.  Sex differences in schizophrenia, a review of the literature.

Authors:  A Leung; P Chue
Journal:  Acta Psychiatr Scand Suppl       Date:  2000

7.  PCP intoxication in seven young children.

Authors:  R H Schwartz; A Einhorn
Journal:  Pediatr Emerg Care       Date:  1986-12       Impact factor: 1.454

Review 8.  Recent advances in the phencyclidine model of schizophrenia.

Authors:  D C Javitt; S R Zukin
Journal:  Am J Psychiatry       Date:  1991-10       Impact factor: 18.112

9.  PCP intoxication in young children and infants.

Authors:  M J Welch; G A Correa
Journal:  Clin Pediatr (Phila)       Date:  1980-08       Impact factor: 1.168

Review 10.  Ketamine: an update on the first twenty-five years of clinical experience.

Authors:  D L Reich; G Silvay
Journal:  Can J Anaesth       Date:  1989-03       Impact factor: 5.063

View more
  22 in total

1.  Association study of H2AFZ with schizophrenia in a Japanese case-control sample.

Authors:  Daisuke Jitoku; Naoki Yamamoto; Yoshimi Iwayama; Tomoko Toyota; Momo Miyagi; Takeshi Enokida; Yuri Tasaka; Masakazu Umino; Asami Umino; Akihito Uezato; Yasuhide Iwata; Katsuaki Suzuki; Mitsuru Kikuchi; Tasuku Hashimoto; Nobuhisa Kanahara; Akeo Kurumaji; Takeo Yoshikawa; Toru Nishikawa
Journal:  J Neural Transm (Vienna)       Date:  2014-11-13       Impact factor: 3.575

2.  Heat shock protein 70 gene polymorphisms are associated with paranoid schizophrenia in the Polish population.

Authors:  Malgorzata Kowalczyk; Aleksander Owczarek; Renata Suchanek; Monika Paul-Samojedny; Anna Fila-Danilow; Paulina Borkowska; Krzysztof Kucia; Jan Kowalski
Journal:  Cell Stress Chaperones       Date:  2013-07-28       Impact factor: 3.667

Review 3.  Unraveling the genetic architecture of copy number variants associated with schizophrenia and other neuropsychiatric disorders.

Authors:  Timothy P Rutkowski; Jason P Schroeder; Georgette M Gafford; Stephen T Warren; David Weinshenker; Tamara Caspary; Jennifer G Mulle
Journal:  J Neurosci Res       Date:  2016-11-08       Impact factor: 4.164

4.  Genetic variability in scaffolding proteins and risk for schizophrenia and autism-spectrum disorders: a systematic review.

Authors:  Jordi Soler; Lourdes Fañanás; Mara Parellada; Marie-Odile Krebs; Guy A Rouleau; Mar Fatjó-Vilas
Journal:  J Psychiatry Neurosci       Date:  2018-05-28       Impact factor: 6.186

5.  Genetic variability in scaffolding proteins and risk for schizophrenia and autism-spectrum disorders: a systematic review.

Authors:  Jordi Soler; Lourdes Fañanás; Mara Parellada; Marie-Odile Krebs; Guy A Rouleau; Mar Fatjó-Vilas
Journal:  J Psychiatry Neurosci       Date:  2018-07       Impact factor: 6.186

6.  Differential genetic associations and expression of PAPST1/SLC35B2 in bipolar disorder and schizophrenia.

Authors:  Akihito Uezato; Daisuke Jitoku; Dai Shimazu; Naoki Yamamoto; Akeo Kurumaji; Yoshimi Iwayama; Tomoko Toyota; Takeo Yoshikawa; Vahram Haroutunian; Eduard Bentea; Jarek Meller; Courtney R Sullivan; James H Meador-Woodruff; Robert E McCullumsmith; Toru Nishikawa
Journal:  J Neural Transm (Vienna)       Date:  2022-05-02       Impact factor: 3.850

7.  Convergent and distributed effects of the 3q29 deletion on the human neural transcriptome.

Authors:  Esra Sefik; Ryan H Purcell; Elaine F Walker; Gary J Bassell; Jennifer G Mulle
Journal:  Transl Psychiatry       Date:  2021-06-15       Impact factor: 6.222

8.  Opposing actions of the synapse-associated protein of 97-kDa molecular weight (SAP97) and Disrupted in Schizophrenia 1 (DISC1) on Wnt/β-catenin signaling.

Authors:  M Boccitto; S Doshi; I P Newton; I Nathke; R Neve; F Dong; Y Mao; J Zhai; L Zhang; R Kalb
Journal:  Neuroscience       Date:  2016-03-26       Impact factor: 3.590

Review 9.  Pathogenetic model for Tourette syndrome delineates overlap with related neurodevelopmental disorders including Autism.

Authors:  R A Clarke; S Lee; V Eapen
Journal:  Transl Psychiatry       Date:  2012-09-04       Impact factor: 6.222

10.  Population-specific haplotype association of the postsynaptic density gene DLG4 with schizophrenia, in family-based association studies.

Authors:  Shabeesh Balan; Kazuo Yamada; Eiji Hattori; Yoshimi Iwayama; Tomoko Toyota; Tetsuo Ohnishi; Motoko Maekawa; Manabu Toyoshima; Yasuhide Iwata; Katsuaki Suzuki; Mitsuru Kikuchi; Takeo Yoshikawa
Journal:  PLoS One       Date:  2013-07-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.